We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Truist raised the firm’s price target on Elevance Health (ELV) to $510 from $480 and keeps a Buy rating on the shares as part of a broader ...

Because this number is lower than its revenue growth, we can see the average customer spent more money each year on the company’s products and services. This quarter, Elevance Health grew its ...

Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been given a consensus rating of “Moderate Buy” by the ...

Indianapolis-based health Elevance Health’s board is recommending its investors reject a shareholder proposal that asks the ...

In its first quarter 2025 investor letter, GreensKeeper Asset Management emphasized stocks such as Elevance Health, Inc. (NYSE:ELV). Elevance Health, Inc. (NYSE:ELV) is a health benefits company ...

3 Reasons We’re Fans of Elevance Health (ELV) Elevance Health trades at $423.06 per share and has stayed right on track with the overall market, losing 14% over the last six months while the S&P ...

Guggenheim initiated coverage of Elevance Health (ELV) with a Buy rating and $518 price target The firm launched coverage on 11 healthcare ...

Elevance Health (NYSE:ELV) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. In the table below, you'll find a summary of ...

and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. Receive News & Ratings for Elevance Health ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $477.08, along with a high estimate of $512.00 and a low estimate of $405.40. Marking an ...